Tadalafil 2.5 or 5mg administered once daily for 12 weeks in men with both erectile dysfunction and signs and symptoms of benign prostatic hyperplasia: Results of a randomized, placebo-controlled, double-blind study

Russell Blair Egerdie, Stephen Auerbach, Claus Roehrborn, Pierre Costa, Martin Sanchez Garza, Anne L. Esler, David G. Wong, Roberta J. Secrest

Research output: Contribution to journalArticlepeer-review

120 Scopus citations

Fingerprint

Dive into the research topics of 'Tadalafil 2.5 or 5mg administered once daily for 12 weeks in men with both erectile dysfunction and signs and symptoms of benign prostatic hyperplasia: Results of a randomized, placebo-controlled, double-blind study'. Together they form a unique fingerprint.

Medicine & Life Sciences